DataMEDS AI Inc(MEDS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
October 7 at 5:28 AM ET (Korea 10/7 18:28)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -43.3 | Insider Own | 51.83% | Shs Outstand | 2.8M | Perf Week | -16.35% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.5M | Perf Month | 235.15% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | - | Inst Own | 1.62% | Short Float | 27.96% | Perf Quarter | 6.6% |
| Income | -0.09B | P/S | 1.21 | EPS this Y | - | Inst Trans | 4.16% | Short Ratio | 0.08 | Perf Half Y | -51.58% |
| Sales | 0.01B | P/B | - | EPS next 5Y | - | ROA | -202.97% | Short Interest | 0.43M | Perf YTD | -84.63% |
| Book/sh | -6.88 | P/C | 3.96 | EPS past 3/5Y | -2054.2% - | ROE | -927.67% | 52W High | -95.79% ($73.00) | Perf Year | -91.43% |
| Cash/sh | 0.78 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 273.25% ($0.82) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -15.07% | Gross Margin | -119.55% | Volatility(W/M) | 12.07% 44.65% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 5 | Sales Y/Y TTM | -78.16% | Oper. Margin | -719.27% | ATR (14) | 0.94 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.1 | EPS Q/Q | -34.99% | Profit Margin | -1100.3% | RSI (14) | 50.87 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.14 | Sales Q/Q | -77.15% | SMA20 | -3.01% ($3.17) | Beta | -3.49 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | 2026/8/17 | SMA50 | 32.17% ($2.32) | Rel Volume | 0.11 | Prev Close | $3.35 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | 63.64% - | SMA200 | -59.2% ($7.52) | Avg Volume(3M) | 5.72M | Price | $3.07 |
| IPO | 2025/2/21 | Option/Short | No/Yes | Trades | 2831 | Volume | 640,107 | Change | -8.36% |
A US healthcare IT company that uses artificial intelligence to connect prescription data with pharmacy networks. It operates a pharmacy dispensing support platform, a smart-contract-based distribution platform, and patient medication adherence management tools, and aims to vertically integrate adjacent businesses across technology, pharmacy, pharmaceuticals, and telemedicine.
Over the past 1 year, on the lower side
96% below its 1-year high.
Traded less than usual That is 11% of its average volume.
MEDS has weak earnings and a weak balance sheet
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $121. Peers typically go for $296.
Tap to view numbers
Holding long would have lost money
Tap to view numbers
No dividend
There is no profit to distribute yet.
Short interest is a burden
28.0% of the float is sold short.
Tap to view numbers
It ranks #10 of 10 in the industry
Based on market cap of $10M.
FOCL#6 EDAP TMS SA ADR $160M PER - 
ACH#7 Accendra Health Inc $36M PER - 
COSM#8 Cosmos Health Inc $32M PER - 
YI#9 111 Inc ADR $16M PER - MEDS#10 DataMEDS AI Inc $10M PER - 
FAQ
What kind of company is MEDS?
MEDS belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of MEDS?
The market cap of MEDS is approximately $10M, ranking 5,492 within its sector.
What is the 52-week high and low for MEDS?
MEDS has recorded a 52-week high of $73.00 and a low of $0.82.
